SHC014748M
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SHC014748M, covering 2020-07-14 to 2021-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma [Phase 2]